Hypertension and cognitive impairment: the standpoint of evidence-based medicine

• Main Authors: T. M. Ostroumova, V. A. Parfenov, O. D. Ostroumova
• Format: Article
• Language: Russian
• Published: IMA-PRESS LLC 2017-12-01
• Series: Nevrologiâ, Nejropsihiatriâ, Psihosomatika
• Subjects: hypertension; cognitive impairment; clinical manifestations; diagnosis; treatment.
• Online Access: https://nnp.ima-press.net/nnp/article/view/800

Hypertension is one of the main modifiable risk factors for cognitive impairment (CI) and dementia in middle-aged and elderly patients. CI occurs in patients with hypertension even with its short duration and is manifested by controlling dysfunctiona and cognitive speed decline. The paper presents the results of a neuropsychological examination in 50 patients of middle age (47.54±5.2 years) with short-term (2.6±5.5 years) and uncomplicated hypertension. Stable blood pressure normalization during antihypertensive therapy improves cognitive function and prevents the progression of CI and the development of dementia. The use of nicergoline in patients with hypertension and CI is  discussed.